Medicine & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Athenagen, Inc.
Athenagen appoints John Donovan as chief financial officer
June 2nd, 2006
Athenagen, Inc., a privately held biopharmaceutical company, announced the appointment of John Donovan as the company's first full-time chief financial officer. Donovan has more than a decade of biotechnology finance experience both as an investment banker and as a member of senior management within InterMune, most recently as VP, Strategic Planning & Analysis. "It is with great pleasure that we welcome John to Athenagen," commented Scott Harkonen, MD, president and CEO. "His leadership ability and proven track record, both on Wall Street and in a corporate setting, will be great assets to Athenagen as we ramp up operations." At...
Source: Medicine & Law Weekly (2006-06-02)
|
